✦ LIBER ✦

758 FREQUENCY OF ELEVATED BIOMARKERS IN PATIENTS WITH CRYPTOGENIC HEPATOCELLULAR CARCINOMA

✍ Scribed by N. Taura; T. Ichikawa; H. Miyaaki; H. Shibata; K. Nakao

Book ID: 117380968
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 56 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60771-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatocellular Carcinoma in Patients Wit

Hepatocellular Carcinoma in Patients With Cryptogenic Cirrhosis

✍ Giannini, Edoardo Giovanni; Marabotto, Elisa; Savarino, Vincenzo; Trevisani, Fra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 501 KB

Elevated serum chromogranin A in patient

Elevated serum chromogranin A in patients with hepatocellular carcinoma

✍ N. Leone; R. Pellicano; F. Brunello; M. Rizzetto; A. Ponzetto 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 53 KB

Elevated serum level of glycolipid sulfo

Elevated serum level of glycolipid sulfotransferase in patients with hepatocellular carcinoma

✍ Gasa, S.; Casl, M-T.; Jin, T.; Kamio, K.; Uehara, Y.; Miyazaki, T.; Makita, A. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Plasma Biomarkers as Predictors of Outco

Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma

✍ Llovet, J. M.; Pena, C. E. A.; Lathia, C. D.; Shan, M.; Meinhardt, G.; Bruix, J. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 596 KB

Striking elevation in plasma nociceptin

Striking elevation in plasma nociceptin level in patients with hepatocellular carcinoma

✍ Szalay, Ferenc; Hantos, Monika B.; Horvath, Andrea; Lakatos, Laszlo P.; Folhoffe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 478 KB

Occult hepatitis B infection and HBV rep

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma

✍ Danny Ka Ho Wong; Fung Yu Huang; Ching Lung Lai; Ronnie Tung Ping Poon; Wai Kay 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

We aimed to investigate the incidence of occult hepatitis B infection (OBI) in patients with ''cryptogenic'' hepatocellular carcinoma (HCC) and to study the HBV replicative activity in these patients. Tumorous and adjacent nontumorous liver tissues were obtained from 33 cryptogenic HCC patients and